best online weight loss medication programs compounded tirzepatide injections 1 and GIP therapy Compounded GLP-1 - Semaglutide &

#GLP1 #PeptideTherapy #CravingControl #InsulinSupport #PrivatePractice To view or add a comment, sign in Common Side Effects of GLP1 Therapies GLP1 receptor agonists (like Ozempic, Wegovy, etc.) can offer significant benefits in weight and metabolic controlbut they come with possible side effects, including nausea, diarrhea, vomiting, constipation, and mild abdominal discomfort

A board-certified physician is your partner in this process

Control Clin Trials

This is the first key shift in perspective: GLP-1 medications are system-level metabolic therapies, not simply appetite suppressants

In the STEP-1 trial of 1,961 adults (Wilding and colleagues, Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021), participants on semaglutide 2.4 mg lost an average of 14.9 percent of their body weight at 68 weeks, compared to 2.4 percent on placebo